External Advisory Board

The External Advisory Board (EAB) consists of internationally recognised institutions in the field of neurology and systems biology. The following members have agreed to bring in their expertise and advise the project on strategic issues:

  • Photo of Anthony Lang
    Prof. Anthony Lang
    is Professor and Director of the Division of Neurology at the University of Toronto, the Jack Clark Chair for Parkinson’s Disease Research at the University of Toronto and Director of the Edmond J. Safra Program in Parkinson’s Disease at the University Health Network and the University of Toronto. Dr. Lang was one of the founding members and initial Executive Committee members of the Parkinson Study Group (PSG). He has served on multiple Steering Committees for important clinical research trials including the first large scale study of neuroprotective therapies in Parkinson’s disease (the DATATOP trial) carried out by the PSG.
  • Photo of Thomas Gasser
    Prof. Thomas Gasser
    is Director of the Department of Neurodegenerative Diseases at the Hertie Institute for Clinical Brain Research at the University of Tübingen, Germany. His main areas of research are the genetic and molecular basis of Parkinson’s disease, dystonia and other movement disorders as well as their diagnosis and treatment.
    (Photo: HIH, photographer Ingo Rappers)
  • Photo of Walter Kolch
    Prof. Walter Kolch
    is Director of Systems Biology Ireland (SBI). He has built an international reputation across the areas of MAPK signalling, proteomics, and cancer research, especially in regard to using systems biology approaches. Prof. Kolch published over 230 original articles and currently coordinates 2 multi-partner EU-FP7 Health programmes and a Marie Curie COFUND postdoctoral fellowship programme.
  • Photo of Olaf Wolkenhauer
    Prof. Olaf Wolkenhauer
    is Director of the Department of Systems Biology and Bioinformatics at the University of Rostock. Through his role in establishing systems biology in Europe, he has been a regular advisor to funding bodies and more recently has helped to define and establish the field of systems medicine through his involvement in the coordination action CaSyM, a multidisciplinary European consortium that joined forces to develop an implementation strategy for Systems Medicine.
  • Photo of Philip Seibler
    Prof. Philip Seibler
    is Head of the Section ‘Applied Stem Cell Biology’ at the Institute of Neurogenetics in Luebeck, Germany. His main research focus lies on induced pluripotent stem cells to generate neuronal disease models.
  • Photo of Anne Grünewald
    Prof. Anne Grünewald
    leads the Molecular and Functional Neurobiology group at the Luxembourg Centre for Systems Biomedicine (LCSB). The research group investigates the link between the mitochondrial genome (mtDNA), mitochondrial dysfunction and neurodegeneration.